Montreux Equity Partners
Growth equitySan Francisco · Growth–Late Stage
Investment thesis
The firm invests growth capital in category-leading, commercial-stage companies in healthcare and financial technology. Target companies typically have highly differentiated products, technologies, or services and $5 to $50 million in annual revenue at the time of investment. Individual checks generally range from $10 to $20 million, with capital used to fuel product expansion and innovation, new market entry, and strategic acquisitions. A cohesive team collaborates across diligence, investment decisions, and portfolio management, bringing complementary operational, financial, and sector expertise to actively support portfolio companies.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 1 of 3 portfolio companiesHealthtech ×1
HQs:United States×1
Investments · 3 tracked
founders shown can be your intro pathHealthtechSan Diego, US
Cam L. Garner(Director)William F. Strauss(Director)David F. Hale(Executive Chairman)Howard Palefsky(Director)Kathleen D. Scott(Secretary, Treasurer and Chief Financial Officer)Frederick G. Sliter III(President and Chief Executive Officer)
Board seatHoward Palefsky· per SEC Form D · $5M raise · filed Aug 2016
Digital healthcare technology company formed by the merger of Kareo and PatientPop.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does Montreux Equity Partners invest at?
- Montreux Equity Partners invests at the Growth, Late Stage stages.
- What is Montreux Equity Partners's typical check size?
- Montreux Equity Partners typically writes checks of $10M – $20M.
- What sectors does Montreux Equity Partners focus on?
- Montreux Equity Partners focuses on Digital Health, Fintech, Healthtech.
- Where is Montreux Equity Partners located?
- Montreux Equity Partners is headquartered in San Francisco, US.
Similar investors
500 Global (formerly 500 Startups) is a venture capital firm that invests in startups worldwide and runs programs for founders and investors.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
OneVentures is a later-stage venture capital firm that backs technology and healthcare companies, providing growth equity and credit alongside strategic and operational support.
Claret Capital Partners is a European venture debt provider that finances technology, life sciences and impact companies, having deployed over €1.5bn across more than 200 companies.